Quick Answer
SOLESENCE, INC. reported Research And Development Expense of $4.09 million for the year ending 2025.
- SOLESENCE, INC. showed an increase of +6.6% in Research And Development Expense from 2024 to 2025.
- This data is from SOLESENCE, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), SOLESENCE, INC.'s Research And Development Expense has grown by 153.3%.
- Historical annual values: Fiscal year 2025: $4.09 million | Fiscal year 2024: $3.84 million | Fiscal year 2023: $3.84 million | Fiscal year 2022: $3.04 million | Fiscal year 2021: $2.24 million | Fiscal year 2020: $1.57 million | Fiscal year 2019: $1.87 million | Fiscal year 2018: $2.06 million | Fiscal year 2017: $1.74 million | Fiscal year 2016: $1.55 million | Fiscal year 2015: $1.27 million | Fiscal year 2014: $1.34 million | Fiscal year 2013: $1.68 million | Fiscal year 2012: $1.63 million | Fiscal year 2011: $1.74 million | Fiscal year 2010: $1.61 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: